Health: The FDA has made leadership changes in its drug and biologics divisions as part of an organizational restructuring.
The U.S. FDA is making changes in its leadership for drug and biologics regulation, just days after the exit of former commissioner Marty Makary. Stay tuned for updates on how these shifts might impact public health! #FDA #HealthNews
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
